FGF-2 was found to improve sensorimotor deficits and to reduce infarct size following cerebral ischemia in adult rats [35], and neutralizing antibodies to FGF-2 blocks recovery from motor cortex lesions [36]. This evidence concerns the gene FGF2 and Cerebral ischemia.